Status:
UNKNOWN
Level of HER2-neu Gene Amplification an Response to Trastuzumab
Lead Sponsor:
Istituto Clinico Humanitas
Conditions:
Advanced Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Primary objective of the study is to evaluate the correlation between level of HER2-neu gene amplification evalued by dual-color Fluorescent in-situ hybridization (FISH) test and time to progression (...
Eligibility Criteria
Inclusion
- HER2-positive breast cancer Trastuzumab-containing regimen delivered for advanced disease Tumor sample available at Pathology Archive
Exclusion
- HER2-negative advanced breast cancer Pretreatment with trastuzumab
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00874146
Start Date
March 1 2009
End Date
December 1 2009
Last Update
September 2 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Clinco Humanitas
Rozzano, Milan, Italy, 20089